Zelboraf 240 MG tablet UU 112S
Ended Awarded
- Contract number
- SPE2DB25FQWPG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,116
Award facts
- Contract value 100% obligated
- $14,115.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,115.73 to DMS Pharmaceutical Group Inc. for 112 tablets of Zelboraf 240 mg on August 28, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order carries no set-aside designation. Zelboraf (vemurafenib) is a targeted cancer therapy used in the treatment of melanoma and other malignancies, indicating this order supports the pharmaceutical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor and has been registered in SAM.gov since 2001.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to procure a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support Department of Defense healthcare operations worldwide. As a primary supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established itself as a critical vendor for delivering specialty medications and oncology treatments to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FQWPG?
SPE2DB25FQWPG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FQWPG worth?
The government has obligated $14,116 on SPE2DB25FQWPG.
Is contract SPE2DB25FQWPG an order under another contract?
Yes. SPE2DB25FQWPG is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWPG competed?
The extent of competition for SPE2DB25FQWPG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award